Table 3 DAVID Gene Ontology (GO) functional annotation on the prostate tumor models during their transition from in vitro to in vivo growth
Accession | Gene Ontology Term generated from DAVID analysis of human-RNA-only-binding probe sets | Gene count | PValue | Fold enrichment | Benjamini | False discovery rate (%) |
|---|---|---|---|---|---|---|
GO:0044421 | extracellular region part | 14 | 4.68E-07 | 5.33 | 4.12E-05 | 5.07E-04 |
GO:0005615 | extracellular space | 12 | 8.91E-07 | 6.40 | 3.92E-05 | 9.65E-04 |
GO:0005576 | extracellular region | 18 | 3.26E-06 | 3.27 | 9.55E-05 | 3.53E-03 |
GO:0005578 | proteinaceous extracellular matrix | 7 | 1.75E-04 | 7.99 | 3.84E-03 | 0.19 |
GO:0031012 | extracellular matrix | 7 | 2.63E-04 | 7.41 | 4.61E-03 | 0.28 |
GO:0009611 | response to wounding | 7 | 0.0019 | 5.10 | 0.6674 | 2.70 |
GO:0019932 | second-messenger-mediated signaling | 5 | 0.0027 | 8.22 | 0.5559 | 3.96 |
GO:0001568 | blood vessel development | 5 | 0.0032 | 7.89 | 0.4668 | 4.58 |
GO:0001944 | vasculature development | 5 | 0.0035 | 7.70 | 0.4022 | 4.99 |
GO:0005581 | collagen | 3 | 0.0039 | 31.30 | 0.0553 | 4.11 |
GO:0048870 | cell motility | 5 | 0.0071 | 6.30 | 0.4510 | 9.91 |
GO:0051674 | localization of cell | 5 | 0.0071 | 6.30 | 0.4510 | 9.91 |
GO:0008009 | chemokine activity | 3 | 0.0072 | 22.88 | 0.6673 | 8.26 |
GO:0006935 | chemotaxis | 4 | 0.0074 | 9.66 | 0.4245 | 10.41 |
GO:0042330 | taxis | 4 | 0.0074 | 9.66 | 0.4245 | 10.41 |
GO:0001501 | skeletal system development | 5 | 0.0081 | 6.06 | 0.4132 | 11.24 |
GO:0042379 | chemokine receptor binding | 3 | 0.0081 | 21.48 | 0.4633 | 9.29 |
GO:0005125 | cytokine activity | 4 | 0.0166 | 7.20 | 0.5732 | 18.13 |
GO:0005201 | extracellular matrix structural constituent | 3 | 0.0236 | 12.24 | 0.5992 | 24.90 |